Sign In
Buy OCX
$3.20
+0 (+0%)
At Close: Sep 16, 2025
Edited Transcript of OCX earnings conference call or presentation 12-May-20 8:30pm GMT
07:18am, Wednesday, 13'th May 2020
Q1 2020 OncoCyte Corp Earnings Call
Oncocyte Provides Corporate Update And Reports First Quarter 2020 Financial Results
08:05pm, Tuesday, 12'th May 2020
Announced Final Medicare LCD from Palmetto for DetermaRx™, Potentially Establishing Medicare Coverage for up to 70% of Eligible Early-Stage NSCLC Patients Signed First.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Lineage Cell Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update
12:00am, Thursday, 07'th May 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medic
Oncocyte to Report First Quarter 2020 Financial Results on Tuesday, May 12
12:00pm, Tuesday, 05'th May 2020
IRVINE, Calif., May 05, 2020 -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision.
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
Oncocyte Announces Final Medicare LCD from Palmetto for DetermaRx™
06:21pm, Thursday, 30'th Apr 2020
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
Oncocyte Announces $10.7 Million Registered Offering
12:00pm, Friday, 24'th Apr 2020
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
Edited Transcript of OCX earnings conference call or presentation 25-Mar-20 8:30pm GMT
02:55am, Thursday, 16'th Apr 2020
Q4 2019 OncoCyte Corp Earnings Call
Read This Before Selling OncoCyte Corporation (NYSEMKT:OCX) Shares
07:35pm, Tuesday, 07'th Apr 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Medical Services Outlook Bright Amid Coronavirus Crisis
01:00pm, Tuesday, 07'th Apr 2020
Medical Services Outlook Bright Amid Coronavirus Crisis
Medical Services Outlook Bright Amid Coronavirus Crisis
01:00pm, Tuesday, 07'th Apr 2020
Despite the coronavirus-led worldwide sales disruption, medical services is one of the few sectors witnessing industry-wide growth right now.
Oncocyte to Participate at 19th Annual Needham Virtual Healthcare Conference
12:00pm, Tuesday, 07'th Apr 2020
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
